Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study
- PMID: 30721954
- DOI: 10.1093/ecco-jcc/jjz024
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study
Abstract
Background and aims: The aims of this study were to determine the prevalence of fatigue in patients with inflammatory bowel disease [IBD], to identify the factors associated with fatigue and its severity, to assess the impact of fatigue on quality of life [QoL], and to evaluate the relationship between fatigue and sleep disorders.
Methods: This was a prospective multicentre study conducted at 22 Spanish centres. Consecutive patients followed at IBD Units were included. Fatigue was evaluated with the Fatigue Severity Scale [FSS] and the Fatigue Impact Scale [FIS]. Quality of life and sleep quality were assessed using the IBD Questionnaire-Short Form [IBDQ-9] and the Pittsburgh Sleep Quality Index [PSQI], respectively.
Results: A total of 544 consecutive adult IBD patients were included [50% women, mean age 44 years, 61% Crohn's disease]. The prevalence of fatigue was 41% (95% confidence interval [CI] = 37-45%). The variables associated with an increased risk of fatigue were: anxiety [OR = 2.5, 95% CI = 1.6-3.7], depression [OR = 2.4, 95% CI = 1.4-3.8], presence of extraintestinal manifestations [EIMs] [OR = 1.7, 95% CI = 1.1-2.6], and treatment with systemic steroids [OR = 2.8, 95% CI = 1.4-5.7]. The presence of EIMs [regression coefficient, RC = 8.2, 95% CI = 2.3-14.2], anxiety [RC = 25.8, 95% CI = 20.0-31.5], depression [RC = 30.6, 95% CI = 24.3-37.0], and sleep disturbances [RC = 15.0, 95% CI = 9.3-20.8] were associated with severity of fatigue. Patients with fatigue had a significantly decreased IBDQ-9 score [p < 0.001].
Conclusions: The prevalence of fatigue in IBD patients is remarkably high and has a negative impact on QoL. Therapy with systemic steroids is associated with an increased risk of fatigue. The severity of fatigue is associated with anxiety, depression, sleep disorders, and the presence of EIMs. Fatigue was not associated with anaemia, disease activity or anti-TNF therapy.
Keywords: Crohn’s disease; Inflammatory bowel disease; anxiety; depression; fatigue; quality of life; sleep; ulcerative colitis.
Copyright © 2019 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world.Indian J Gastroenterol. 2024 Feb;43(1):226-236. doi: 10.1007/s12664-023-01462-5. Epub 2023 Oct 18. Indian J Gastroenterol. 2024. PMID: 37851205
-
Impact of pain, fatigue and bowel incontinence on the quality of life of people living with inflammatory bowel disease: A UK cross-sectional survey.United European Gastroenterol J. 2025 Apr;13(3):364-375. doi: 10.1002/ueg2.12668. Epub 2024 Oct 19. United European Gastroenterol J. 2025. PMID: 39425758 Free PMC article.
-
The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients.Scand J Gastroenterol. 2019 Dec;54(12):1458-1466. doi: 10.1080/00365521.2019.1697897. Epub 2019 Dec 2. Scand J Gastroenterol. 2019. PMID: 31791216
-
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2021 May;6(5):359-370. doi: 10.1016/S2468-1253(21)00014-5. Epub 2021 Mar 12. Lancet Gastroenterol Hepatol. 2021. PMID: 33721557
-
Sleep and Fatigue in IBD: an Unrecognized but Important Extra-intestinal Manifestation.Curr Gastroenterol Rep. 2020 Jan 30;22(2):8. doi: 10.1007/s11894-020-0746-x. Curr Gastroenterol Rep. 2020. PMID: 32002666 Review.
Cited by
-
Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease.J Neuroinflammation. 2021 Jun 14;18(1):135. doi: 10.1186/s12974-021-02175-2. J Neuroinflammation. 2021. PMID: 34127024 Free PMC article. Review.
-
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study.J Clin Med. 2022 Apr 27;11(9):2455. doi: 10.3390/jcm11092455. J Clin Med. 2022. PMID: 35566580 Free PMC article.
-
Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases.Sci Rep. 2021 Jul 27;11(1):15251. doi: 10.1038/s41598-021-94685-5. Sci Rep. 2021. PMID: 34315951 Free PMC article.
-
Fatigue in Inflammatory Bowel Diseases: Etiologies and Management.Adv Ther. 2020 Jan;37(1):97-112. doi: 10.1007/s12325-019-01151-w. Epub 2019 Nov 23. Adv Ther. 2020. PMID: 31760611 Free PMC article. Review.
-
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.Inflamm Bowel Dis. 2023 Nov 2;29(11):1723-1729. doi: 10.1093/ibd/izad016. Inflamm Bowel Dis. 2023. PMID: 36790041 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical